| Dr Edgardo Baerga, MD | |
|
2 Center Plz, Tinton Falls, NJ 07724-9744 | |
| (732) 460-5360 | |
| (732) 460-7442 |
| Full Name | Dr Edgardo Baerga |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 28 Years |
| Location | 2 Center Plz, Tinton Falls, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912957895 | NPI | - | NPPES |
| 8988803 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MA07046600 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mid Atlantic Rehabilitation Consultants, Llc | 6002945102 | 2 |
News Archive
AbbVie, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of the first of two planned Phase 3 clinical studies evaluating the safety and efficacy of Elagolix alone or in combination with add-back therapy compared to placebo.
The lightning speed with which scientists developed and tested the COVID-19 vaccine is a true scientific triumph - one that would not have been possible without the more than 70,000 volunteers who participated in clinical trials of the vaccine.
CellAura, the leading producer of fluorescence reagents for drug discovery and life sciences research, today announced a development partnership with Cisbio Bioassays. Under the terms of the agreement, CellAura will provide pharmacologically validated reagents to Cisbio Bioassays that will be applied to Cisbio Bioassays' Tag-lite™ range of non-radioactive assays for cellular studies.
Reallocation of treatment resources could substantially decrease the problem of unmet need for treatment of mental disorders among serious cases in developed and developing countries.
› Verified 1 days ago
| Entity Name | Mid Atlantic Rehabilitation Consultants, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639109887 PECOS PAC ID: 6002945102 Enrollment ID: O20100528000165 |
News Archive
AbbVie, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of the first of two planned Phase 3 clinical studies evaluating the safety and efficacy of Elagolix alone or in combination with add-back therapy compared to placebo.
The lightning speed with which scientists developed and tested the COVID-19 vaccine is a true scientific triumph - one that would not have been possible without the more than 70,000 volunteers who participated in clinical trials of the vaccine.
CellAura, the leading producer of fluorescence reagents for drug discovery and life sciences research, today announced a development partnership with Cisbio Bioassays. Under the terms of the agreement, CellAura will provide pharmacologically validated reagents to Cisbio Bioassays that will be applied to Cisbio Bioassays' Tag-lite™ range of non-radioactive assays for cellular studies.
Reallocation of treatment resources could substantially decrease the problem of unmet need for treatment of mental disorders among serious cases in developed and developing countries.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edgardo Baerga, MD 2 Center Plz, Tinton Falls, NJ 07724-9744 Ph: (732) 460-5360 | Dr Edgardo Baerga, MD 2 Center Plz, Tinton Falls, NJ 07724-9744 Ph: (732) 460-5360 |
News Archive
AbbVie, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of the first of two planned Phase 3 clinical studies evaluating the safety and efficacy of Elagolix alone or in combination with add-back therapy compared to placebo.
The lightning speed with which scientists developed and tested the COVID-19 vaccine is a true scientific triumph - one that would not have been possible without the more than 70,000 volunteers who participated in clinical trials of the vaccine.
CellAura, the leading producer of fluorescence reagents for drug discovery and life sciences research, today announced a development partnership with Cisbio Bioassays. Under the terms of the agreement, CellAura will provide pharmacologically validated reagents to Cisbio Bioassays that will be applied to Cisbio Bioassays' Tag-lite™ range of non-radioactive assays for cellular studies.
Reallocation of treatment resources could substantially decrease the problem of unmet need for treatment of mental disorders among serious cases in developed and developing countries.
› Verified 1 days ago
Scott C Woska, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 35 S Gilbert St, Tinton Falls, NJ 07701 Phone: 732-530-1515 Fax: 732-345-6497 | |
David Bernard Fox, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 776 Shrewsbury Ave, Suite 203, Tinton Falls, NJ 07724 Phone: 732-219-0333 Fax: 732-219-6526 | |
Dr. Jorge Francisco Corzo, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 55 N Gilbert St, Ste 3201, Tinton Falls, NJ 07701 Phone: 732-264-1132 | |
Dr. Priscila N Gonzalez, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 2 Center Plz, Tinton Falls, NJ 07724 Phone: 732-460-5360 Fax: 732-460-7442 | |
Joseph Basilone, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 776 Shrewsbury Ave, Suite 203, Tinton Falls, NJ 07724 Phone: 732-219-0333 Fax: 732-219-6526 | |
Carol Sonatore, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2 Center Plz, Tinton Falls, NJ 07724 Phone: 732-735-2841 |